Cargando…

Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism

BACKGROUND: Tyrosinase-positive oculocutaneous albinism (OCA, type II, OCA2) is an autosomal recessive genetic disease in which the biosynthesis of melanin decreases in the skin, hair, and eyes. OCA2 disease is caused by mutations in OCA2 gene. The gene product plays a role in regulating the pH of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Linya, Zhu, Jianjian, Wang, Jing, Huang, Yazhou, Zhang, Jibo, Wang, Chao, Zhou, Yuan, Peng, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544823/
https://www.ncbi.nlm.nih.gov/pubmed/34707637
http://dx.doi.org/10.3389/fgene.2021.715437
_version_ 1784589897577791488
author Ma, Linya
Zhu, Jianjian
Wang, Jing
Huang, Yazhou
Zhang, Jibo
Wang, Chao
Zhou, Yuan
Peng, Dan
author_facet Ma, Linya
Zhu, Jianjian
Wang, Jing
Huang, Yazhou
Zhang, Jibo
Wang, Chao
Zhou, Yuan
Peng, Dan
author_sort Ma, Linya
collection PubMed
description BACKGROUND: Tyrosinase-positive oculocutaneous albinism (OCA, type II, OCA2) is an autosomal recessive genetic disease in which the biosynthesis of melanin decreases in the skin, hair, and eyes. OCA2 disease is caused by mutations in OCA2 gene. The gene product plays a role in regulating the pH of melanosomes. Up to now, hundreds of OCA2 mutations have been reported and novel variants are still being discovered. METHODS: In this study, we reviewed the records of OCA2 patients who had conducted albinism genetic testing, and then analyzed the clinical and genetic information of 28 OCA2 patients who had been genetically diagnosed by using Sanger sequencing and next-generation sequencing. RESULTS: In this study, we reported 31 variants screened from 28 Chinese OCA2 families, and characterized the detailed molecular and clinical presentations. There were 12 novel variants among all detected variants, including 3 missense variants (p.G393V, p.T482A, and p.R720P), 4 frameshift variants (p.R53Gfs(∗)49, p.N279Kfs(∗)17, p.I469Lfs(∗)4, p.I655Nfs(∗)12), 2 splicing variants (c.1637-2A > G, c.1951 + 1G > C), 2 stopgain variants (p.L278X, p.W652X) and 1 insertion variants (p.P315LinsT). One potential cluster of missense variants was implicated indicating the important roles of the underlying domains in OCA2 pathogenesis. CONCLUSION: Our results were beneficial for diagnosis and precision clinical management for OCA2-related disorder, and this study expanded the mutation spectrum of oculocutaneous albinism.
format Online
Article
Text
id pubmed-8544823
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85448232021-10-26 Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism Ma, Linya Zhu, Jianjian Wang, Jing Huang, Yazhou Zhang, Jibo Wang, Chao Zhou, Yuan Peng, Dan Front Genet Genetics BACKGROUND: Tyrosinase-positive oculocutaneous albinism (OCA, type II, OCA2) is an autosomal recessive genetic disease in which the biosynthesis of melanin decreases in the skin, hair, and eyes. OCA2 disease is caused by mutations in OCA2 gene. The gene product plays a role in regulating the pH of melanosomes. Up to now, hundreds of OCA2 mutations have been reported and novel variants are still being discovered. METHODS: In this study, we reviewed the records of OCA2 patients who had conducted albinism genetic testing, and then analyzed the clinical and genetic information of 28 OCA2 patients who had been genetically diagnosed by using Sanger sequencing and next-generation sequencing. RESULTS: In this study, we reported 31 variants screened from 28 Chinese OCA2 families, and characterized the detailed molecular and clinical presentations. There were 12 novel variants among all detected variants, including 3 missense variants (p.G393V, p.T482A, and p.R720P), 4 frameshift variants (p.R53Gfs(∗)49, p.N279Kfs(∗)17, p.I469Lfs(∗)4, p.I655Nfs(∗)12), 2 splicing variants (c.1637-2A > G, c.1951 + 1G > C), 2 stopgain variants (p.L278X, p.W652X) and 1 insertion variants (p.P315LinsT). One potential cluster of missense variants was implicated indicating the important roles of the underlying domains in OCA2 pathogenesis. CONCLUSION: Our results were beneficial for diagnosis and precision clinical management for OCA2-related disorder, and this study expanded the mutation spectrum of oculocutaneous albinism. Frontiers Media S.A. 2021-10-11 /pmc/articles/PMC8544823/ /pubmed/34707637 http://dx.doi.org/10.3389/fgene.2021.715437 Text en Copyright © 2021 Ma, Zhu, Wang, Huang, Zhang, Wang, Zhou and Peng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Ma, Linya
Zhu, Jianjian
Wang, Jing
Huang, Yazhou
Zhang, Jibo
Wang, Chao
Zhou, Yuan
Peng, Dan
Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism
title Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism
title_full Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism
title_fullStr Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism
title_full_unstemmed Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism
title_short Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism
title_sort genetic analysis of 28 chinese families with tyrosinase-positive oculocutaneous albinism
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544823/
https://www.ncbi.nlm.nih.gov/pubmed/34707637
http://dx.doi.org/10.3389/fgene.2021.715437
work_keys_str_mv AT malinya geneticanalysisof28chinesefamilieswithtyrosinasepositiveoculocutaneousalbinism
AT zhujianjian geneticanalysisof28chinesefamilieswithtyrosinasepositiveoculocutaneousalbinism
AT wangjing geneticanalysisof28chinesefamilieswithtyrosinasepositiveoculocutaneousalbinism
AT huangyazhou geneticanalysisof28chinesefamilieswithtyrosinasepositiveoculocutaneousalbinism
AT zhangjibo geneticanalysisof28chinesefamilieswithtyrosinasepositiveoculocutaneousalbinism
AT wangchao geneticanalysisof28chinesefamilieswithtyrosinasepositiveoculocutaneousalbinism
AT zhouyuan geneticanalysisof28chinesefamilieswithtyrosinasepositiveoculocutaneousalbinism
AT pengdan geneticanalysisof28chinesefamilieswithtyrosinasepositiveoculocutaneousalbinism